Skip to main content
. Author manuscript; available in PMC: 2017 Sep 1.
Published in final edited form as: Breast Cancer Res Treat. 2016 Aug 10;159(2):335–345. doi: 10.1007/s10549-016-3910-0

Table 3.

Relative risks (RR) and 95% confidence intervals (95%CI) for breast cancer according to quintile of intake of whole grain and refined grain foods during early adulthood among women in the Nurses’ Health Study II

Quintile of intake
1 2 3 4 5 Ptrend
Early adulthood total whole grain-food intake

All cases
    Median intake, serving/day 0.1 0.4 0.6 0.9 1.4
    No. of cases/person-years 665/374,554 669/380,529 625/374,930 642/379,035 634/376,807
    Age-adjusted RR (95%CI) 1 1.00 (0.89–1.11) 0.95 (0.85–1.06) 0.98 (0.87–1.09) 0.95 (0.85–1.06) 0.34
    Multivariable RR (95%CI) 1 0.97 (0.87–1.09) 0.92 (0.82–1.03) 0.93 (0.83–1.05) 0.91 (0.81–1.02) 0.11

Premenopausal cases
    Median intake, serving/day 0.2 0.4 0.6 0.9 1.5
    No. of cases/person-years 367/235,540 354/237,799 316/236,259 343/236,473 339/234,973
    Age-adjusted RR (95%CI) 1 0.95 (0.82–1.10) 0.85 (0.73–0.99) 0.93 (0.80–1.08) 0.91 (0.79–1.06) 0.34
    Multivariable RR (95%CI) 1 0.93 (0.80–1.08) 0.84 (0.72–0.98) 0.90 (0.77–1.06) 0.88 (0.75–1.03) 0.19

Postmenopausal cases
    Median intake, serving/day
    No. of cases/person-years 0.1 0.3 0.6 0.9 1.4
    Age-adjusted RR (95%CI) 1 1.00 (0.84–1.21) 1.11 (0.93–1.33) 0.99 (0.82–1.19) 0.99 (0.82–1.19) 0.75
    Multivariable RR (95%CI) 1 0.99 (0.82–1.19) 1.06 (0.88–1.28) 0.95 (0.78–1.15) 0.95 (0.78–1.16) 0.45

Early adulthood total refinedgrain-food intake

All cases
    Median intake, serving/day 1.1 1.6 2.1 2.6 3.5
    No. of cases/person-years 671/377,164 693/377,147 603/377,366 672/377,181 596/376,998
    Age-adjusted RR (95%CI) 1 1.06 (0.95–1.18) 0.93 (0.83–1.04) 1.04 (0.93–1.15) 0.92 (0.83–1.03) 0.13
    Multivariable RR (95%CI) 1 1.01 (0.90–1.12) 0.86 (0.76–0.97) 0.97 (0.86–1.10) 0.89 (0.77–1.02) 0.10

Premenopausal cases
    Median intake, serving/day 1.1 1.6 2.1 2.6 3.5
    No. of cases/person-years 351/236,306 377/236,163 300/236,428 363/236,090 328/236,056
    Age-adjusted RR (95%CI) 1 1.07 (0.93–1.24) 0.86 (0.73–1.00) 1.04 (0.90–1.20) 0.95 (0.82–1.11) 0.46
    Multivariable RR (95%CI) 1 1.04 (0.89–1.21) 0.83 (0.70–0.98) 1.01 (0.85–1.20) 0.94 (0.78–1.14) 0.57

Postmenopausal cases
    Median intake, serving/day 1.0 1.6 2.0 2.5 3.4
    No. of cases/person-years 235/106,060 255/106,200 220/106,178 243/106,114 216/106,181
    Age-adjusted RR (95%CI) 1 1.11 (0.93–1.32) 0.96 (0.80–1.16) 1.07 (0.89–1.28) 0.93 (0.77–1.12) 0.35
    Multivariable RR (95%CI) 1 1.05 (0.87–1.26) 0.87 (0.71–1.07) 0.97 (0.78–1.19) 0.86 (0.68–1.08) 0.14

Multivariable model was stratified by age in months at start of follow-up and calendar year of the current questionnaire cycle and was simultaneously adjusted for smoking (never, past, current 1–14/day, current 15–24/day, current ≥25/day), race (white/non-white), parity and age at first birth (nulliparous, parity ≤2 and age at first birth <25 years, parity≤2 and age at first birth 25–<30 years, parity ≤2 and age at first birth ≥30 years, parity 3–4 and age at first birth <25 years, parity 3–4 and age at first birth 25–<30 years, parity 3–4 and age at first birth ≥30 years, parity ≥5 and age at first birth <25 years, parity ≥5 and age at first birth ≥25 years), height (<62, 62–<65, 65–<68, ≥68 inches), BMI at age 18 years (<18.5, 18.5–<22.5, 22.5–<25, 25.0–<30, ≥30.0 kg/m2), weight change since age 18 (continuous, missing indicator), age at menarche (<12, 12, 13, ≥14 years), family history of breast cancer (yes, no), history of benign breast disease (yes, no), oral contraceptive use (never, past, current), adult alcohol intake (nondrinker, <5, 5–<15,≥15 g/day), physical activity (quintile), energy intake (quintile). In postmenopausal women, we additionally adjusted for hormone use (postmenopausal never users, postmenopausal past users, postmenopausal current users), age at menopause (<45 years, 45 to 46 years, 47 to 48, 49 to 50 years, 51 to 52 years, ≥53 years). Among all women, we additionally adjusted for hormone use and menopausal status (premenopausal, postmenopausal never users, postmenopausal past users, postmenopausal current users, unknown menopausal status) and, age at menopause (premenopausal, unknown menopause, <45 years, 45 to 46 years, 47 to 48, 49 to 50 years, 51 to 52 years, ≥53 years).